查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1465048

耳鼻喉科疾病治疗市场：按治疗类型、疾病类型、最终用户划分 - 全球预测 2024-2030

ENT Disorder Treatment Market by Treatment Type (Device, Drugs), Disorder Type (Ear, Nose, Throat), End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年耳鼻喉疾病治疗市场规模为253.4亿美元，2024年达268.3亿美元，预计2030年将达387.7亿美元，复合年增长率为6.26%。

耳鼻喉科疾病治疗涉及对影响耳、鼻、喉及相关头颈结构的疾病进行全面的医疗和外科治疗。这些疾病的范围从鼻窦感染疾病和听力损失等常见问题到咽喉癌和脑神经疾病等复杂疾病。治疗对于缓解症状、改善生活品质和预防可能导致更严重健康风险的併发症至关重要。由于污染导致的过敏反应和呼吸道疾病的盛行率不断上升，推动了对耳鼻喉科疾病治疗的需求。此外，随着世界老化，人们变得更容易患慢性耳鼻喉疾病，如听力损失和鼻窦。这些人口变化正在推动对增强耳鼻喉科治疗解决方案的需求，以满足老年患者的独特需求。然而，与耳鼻喉科药物和药品相关的严格法规和耗时的核准给主要企业带来了重大挑战。公司经常致力于引入新的治疗方法，以在这种环境下保持敏捷。此外，医疗设备和治疗方法的技术创新显着提高了耳鼻喉科治疗的效果和效率。微创手术和雷射治疗等技术创新正在扩大患者的治疗选择，并促进市场成长。

主要市场统计
基准年[2023] 253.4亿美元
预测年份 [2024] 268.3亿美元
预测年份 [2030] 387.7亿美元
复合年增长率（%） 6.26%

治疗类型 使用耳鼻喉科设备和耳鼻喉科药物治疗严重的耳鼻喉科疾病

医疗设备的进步显着提高了耳鼻喉科疾病患者的生活品质。人工电子耳是一种革命性的设备，可为严重听力损失的人提供声音的感觉。持续性呼吸道阳压呼吸器(CPAP) 机是阻塞型睡眠呼吸中止症患者的重要治疗方法，可在睡眠时保持呼吸道通畅。助听器还可以为听力损失的人放大声音，鼻夹板用于支撑鼻结构并帮助手术或鼻外伤后的正常癒合。同时，药物治疗在耳鼻喉科疾病的管理和治疗中发挥重要作用。发炎药物可以减轻耳、鼻、喉的发炎，有助于缓解疼痛和减轻肿胀。抗生素用于对抗细菌感染，对于细菌性鼻窦和外耳炎等疾病至关重要。抗组织胺有效抑制过敏反应症状，缓解鼻塞、打喷嚏等过敏相关症状。此外，类固醇因其强大的发炎特性而被使用，并且经常在耳鼻喉科领域用于治疗严重的发炎和过敏反应病例。

最终用户：医院和门诊手术中心越来越多地使用耳鼻喉科设备，在提供优质医疗服务的同时提供专业护理。

门诊手术中心已成为患者的便捷选择，并透过提供当天的手术治疗（包括诊断和预防程序）提供住院治疗的有效替代方案。耳鼻喉科诊所在提供耳鼻喉疾病的专业治疗、促进早期诊断和根据患者个别需求制定治疗计划方面发挥着至关重要的作用。医院是治疗链的基本组成部分，拥有先进技术和多学科团队的支持，并有能力治疗从轻微到复杂的频谱耳鼻喉疾病。同时，专科诊所提供特定耳鼻喉科领域的专业知识，由该领域的专家提供优质护理和创新治疗。每个最终使用者在提供适当的护理和改善耳鼻喉科疾病患者的生活品质方面都发挥着重要作用。

区域洞察

在美洲，耳鼻喉科疾病的日益普及和医疗基础设施的改善正在推动市场的显着成长。消费者的高度意识和投资先进治疗（包括微创手术）的意愿正在推动该地区的创新。最近的专利主要集中在新的诊断工具和标靶治疗。该地区的公共和私人投资正在推动研究倡议，特别是在生技药品和精准医学领域。同时，欧洲、中东和非洲地区得到完善的医疗保健系统的支持，并表现出对耳鼻喉科治疗研究和创新的坚定承诺。临床试验和研发的跨境合作在该地区很常见，为新的治疗方法和设备铺平了道路。监管支持也促进了针对不同患者群体的新解决方案进入市场。由于耳鼻喉科相关疾病的增加、人口老化以及医疗基础设施的改善，亚太地区的耳鼻喉科治疗市场正在经历显着增长。在中国、印度等人口众多的国家，由于污染、不良生活习惯、遗传性疾病等因素，对耳鼻喉科治疗的需求不断增加。该地区大型製药公司和新兴本地公司大力投资研发更有效、更实惠的治疗方法，也推动了市场的发展。

FPNV定位矩阵

FPNV定位矩阵对于评估耳鼻喉科市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对耳鼻喉科市场供应商的现状进行富有洞察力和深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4. 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.耳鼻喉科治疗市场的市场规模与预测是多少？

2.耳鼻喉科市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些？

3.耳鼻喉科治疗市场的技术趋势和法规结构是什么？

4.耳鼻喉科市场主要厂商的市场占有率是多少？

5.进入耳鼻喉科疾病治疗市场的合适型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 个体耳、鼻、喉过敏原增加
      • 世界各地的人口正在老化，这增加了对慢性耳鼻喉疾病和听力损失的侵入性治疗的需求。
      • 随着数位化和家庭耳鼻喉科诊断的引入
    • 抑制因素
      • 耳鼻喉科药品及器材核准严格规定
    • 机会
      • 耳鼻喉科疾病诊断与治疗技术的进步
      • 对耳鼻喉科相关疾病的有利政府措施和财政支持
    • 任务
      • 发展中地区对耳鼻喉科疾病及治疗方法缺乏认识
  • 市场区隔分析
    • 治疗类型：使用耳鼻喉仪器及耳鼻喉药治疗严重耳鼻喉疾病
    • 最终使用者：医院和门诊手术中心越来越多地使用耳鼻喉设备来提供高品质的护理，同时提供专业护理。
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章依治疗类型分類的耳鼻喉疾病治疗市场

  • 装置
  • 药物

第七章依障碍类型分類的耳鼻喉科疾病治疗市场

  • 耳朵
  • 鼻子
  • 喉

第八章 耳鼻喉科疾病治疗市场：依最终使用者分类

  • 门诊手术中心
  • 耳鼻喉科诊所
  • 医院
  • 专科诊所

第九章 北美及南美耳鼻喉科市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太耳鼻喉科疾病治疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲/中东/非洲耳鼻喉科治疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Integra (IART) 透过新的收购交易推动耳鼻喉科业务
    • Fifth Sense 与英国耳鼻喉科宣布建立策略伙伴关係，以改善对嗅觉和味觉障碍患者的护理
    • Oto 和 Lindus Health 启动远端试验，以改善患者获得耳鸣治疗的机会
  • 战略分析和建议

第13章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-757B1C9CAFAB

[186 Pages Report] The ENT Disorder Treatment Market size was estimated at USD 25.34 billion in 2023 and expected to reach USD 26.83 billion in 2024, at a CAGR 6.26% to reach USD 38.77 billion by 2030.

ENT disorder treatment encompasses the comprehensive medical and surgical management of conditions affecting the ear, nose, and throat, along with related head and neck structures. These disorders can range from common issues, such as sinus infections and hearing loss, to more complex conditions, like throat cancer or cranial nerve disorders. The treatment is vital for alleviating symptoms, improving quality of life, and preventing complications leading to more severe health risks. The rising prevalence of allergic reactions and respiratory ailments due to pollution has boosted the demand for ENT disorder treatment. In addition, the growing aging population worldwide is more prone to chronic ENT disorders, such as hearing loss and sinusitis. This demographic shift is driving the demand for enhanced ENT treatment solutions to cater to the unique needs of elderly patients. However, the strict regulations associated with ENT drugs and medicine and their lengthy approvals present a significant challenge for the key players. Companies frequently work towards introducing a novel treatment option to remain agile within the landscape. Moreover, technological innovations in medical devices and treatment methods have greatly enhanced the efficacy and efficiency of ENT treatments. Innovations such as minimally invasive surgery and laser treatments have expanded patient treatment options, contributing to market growth.

KEY MARKET STATISTICS
Base Year [2023] USD 25.34 billion
Estimated Year [2024] USD 26.83 billion
Forecast Year [2030] USD 38.77 billion
CAGR (%) 6.26%

Treatment Type: Utilization of ENT devices and ENT medications to cater severe ENT conditions

The advancement in medical devices has significantly improved the quality of life for individuals with ENT disorders. Cochlear implants are revolutionary devices that provide a sense of sound to the profoundly deaf and severely hard of hearing. Continuous positive airway pressure (CPAP) devices are a cornerstone treatment for patients with obstructive sleep apnea, ensuring the airway remains open during sleep. In addition, hearing aids amplify sound for individuals with hearing loss, while nasal splints are used post-surgery or after nasal trauma to support the nose structure and aid in proper healing. On the other hand, medications play a crucial role in managing and treating ENT disorders. Anti-inflammatory drugs help reduce inflammation in the ear, nose, and throat, leading to pain relief and reduced swelling. Antibiotics are prescribed to combat bacterial infections, crucial in conditions such as bacterial sinusitis or ear infections. Antihistamines effectively control allergic reaction symptoms, thereby alleviating nasal congestion, sneezing, and other allergy-related symptoms. Moreover, steroids are used for their potent anti-inflammatory properties, often prescribed for severe cases of inflammation or allergic reactions in the ENT region.

End-User: Increasing usage of ENT devices in hospitals & ambulatory surgical centers offering specialized care while delivering high-quality care

Ambulatory surgical centers have emerged as a convenient option for patients, offering same-day surgical care, including diagnostic and preventive procedures, which is an efficient alternative to hospital admissions. ENT clinics play a pivotal role, providing specialized care focusing on ear, nose, and throat conditions, facilitating early diagnosis and treatment plans tailored to individual patient needs. Hospitals represent a fundamental component of the treatment chain, equipped to handle a comprehensive spectrum of ENT disorders, from mild to complex cases, supported by advanced technologies and multidisciplinary teams. At the same time, specialty clinics offer focused expertise in specific ENT areas, delivering high-quality care and innovative treatments driven by specialists in the field. Each end-user plays a vital role in providing adequate care and enhancing the quality of life for patients with ENT disorders.

Regional Insights

In the Americas, an increasing prevalence of ENT disorders and a robust healthcare infrastructure spurs significant market growth. High consumer awareness and willingness to invest in advanced treatments, including minimally invasive surgeries, drive innovation in this region. Recent patents emphasize novel diagnostic tools and targeted therapies. The region's public and private sector investments fuel research initiatives, notably in biologics and precision medicine. On the other hand, EMEA demonstrates a strong commitment to research and innovation in ENT treatments, buoyed by its well-established healthcare systems. Cross-border collaborations for clinical trials and R&D are common in the region, paving the way for novel therapies and devices. Regulatory support further facilitates market access for new solutions, catering to a diverse patient population. The Asia Pacific region is witnessing significant growth in the ENT disorder treatment market, driven by rising incidences of ENT-related diseases, an aging population, and improvements in healthcare infrastructure. Countries such as China and India, with their large populations, are seeing an increase in the demand for ENT treatments due to factors including pollution, poor lifestyle choices, and genetic conditions. The presence of significant pharmaceutical companies and emerging local players in the region investing heavily in R&D for more effective and affordable treatments is also propelling the market forward.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the ENT Disorder Treatment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the ENT Disorder Treatment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the ENT Disorder Treatment Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., ALK-Abello AS, Apikos Pharma, AstraZeneca PLC, Bayer AG, Cipla Limited, Covis Pharma BV, Dr. Reddy's Laboratories, F. Hoffmann-La Roche AG, Fennec Pharmaceuticals Inc., GlaxoSmithKline PLC, Integra Lifesciences Corporation, Integra Lifesciences CorporationAbbVie Inc., Intersect ENT, Inc. by Medtronic PLC, Johnson & Johnson Services, Inc., Karl Storz, Merck & Co., Inc., Novartis AG, Olympus Corporation, OptiNose US, Inc., Pfizer Inc., Sanofi SA, Sensorion SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Vitaris Inc..

Market Segmentation & Coverage

This research report categorizes the ENT Disorder Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Treatment Type
    • Device
      • Cochlear Implants
      • Continuous Positive Airway Pressure Devices
      • Hearing Aids
      • Nasal Splints
    • Drugs
      • Anti-inflammatory Drugs
      • Antibiotics
      • Antihistamines
      • Steroids
  • Disorder Type
    • Ear
      • Meniere's Disease
      • Otitis Externa
      • Otitis Media
      • Otomycosis
    • Nose
      • Nasal Polyps
      • Rhinitis
      • Sinusitis
    • Throat
      • Pharyngitis
      • Tonsillitis
      • Tonsillopharyngitis
  • End-User
    • Ambulatory Surgical Centers
    • ENT Clinics
    • Hospitals
    • Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the ENT Disorder Treatment Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the ENT Disorder Treatment Market?

3. What are the technology trends and regulatory frameworks in the ENT Disorder Treatment Market?

4. What is the market share of the leading vendors in the ENT Disorder Treatment Market?

5. Which modes and strategic moves are suitable for entering the ENT Disorder Treatment Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. The rising prevalence of ear, nose, and throat allergens among individuals
      • 5.1.1.2. The growing aging population worldwide and the need of invasive care for chronic ENT disorders and hearing loss
      • 5.1.1.3. Owing adoption of digital and home-based ENT diagnosis
    • 5.1.2. Restraints
      • 5.1.2.1. Strict regulations associated with the approval of ENT drugs and devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in the diagnostic and treatment procedures of ENT disorder
      • 5.1.3.2. Favorable government initiatives and funding for ENT-related diseases
    • 5.1.4. Challenges
      • 5.1.4.1. Insufficient awareness about ENT disorders and available treatments in underdeveloped regions
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Treatment Type: Utilization of ENT devices and ENT medications to cater severe ENT conditions
    • 5.2.2. End-User: Increasing usage of ENT devices in hospitals & ambulatory surgical centers offering specialized care while delivering high-quality care
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. ENT Disorder Treatment Market, by Treatment Type

  • 6.1. Introduction
  • 6.2. Device
  • 6.3. Drugs

7. ENT Disorder Treatment Market, by Disorder Type

  • 7.1. Introduction
  • 7.2. Ear
  • 7.3. Nose
  • 7.4. Throat

8. ENT Disorder Treatment Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. ENT Clinics
  • 8.4. Hospitals
  • 8.5. Specialty Clinics

9. Americas ENT Disorder Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific ENT Disorder Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa ENT Disorder Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Integra (IART) to Advance ENT Division with New Buyout Deal
    • 12.3.2. Fifth Sense and ENT UK Announce Strategic Partnership to Improve Care for People Affected by Smell and Taste Disorders
    • 12.3.3. Oto and Lindus Health Launch a Remote Trial to Increase Patient Access to Tinnitus Therapy
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. ENT DISORDER TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. ENT DISORDER TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ENT DISORDER TREATMENT MARKET DYNAMICS
  • FIGURE 7. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ENT DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ENT DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ENT DISORDER TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. ENT DISORDER TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ENT DISORDER TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY COCHLEAR IMPLANTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY COCHLEAR IMPLANTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY HEARING AIDS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY HEARING AIDS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY NASAL SPLINTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY NASAL SPLINTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY STEROIDS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY STEROIDS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY EAR, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY EAR, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY MENIERE'S DISEASE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY MENIERE'S DISEASE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY OTITIS EXTERNA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY OTITIS EXTERNA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY OTITIS MEDIA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY OTITIS MEDIA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY OTOMYCOSIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY OTOMYCOSIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY NASAL POLYPS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY NASAL POLYPS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY RHINITIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY RHINITIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY SINUSITIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY SINUSITIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY PHARYNGITIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY PHARYNGITIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 63. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY TONSILLITIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 64. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY TONSILLITIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 65. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY TONSILLOPHARYNGITIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 66. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY TONSILLOPHARYNGITIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 67. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 68. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 69. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 70. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 71. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY ENT CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 72. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY ENT CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 73. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 74. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 75. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 76. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 77. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
  • TABLE 80. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
  • TABLE 81. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 82. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 83. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
  • TABLE 84. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
  • TABLE 85. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
  • TABLE 86. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
  • TABLE 87. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
  • TABLE 88. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
  • TABLE 89. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
  • TABLE 90. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
  • TABLE 91. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 92. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 93. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 94. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 95. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 96. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 97. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
  • TABLE 98. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
  • TABLE 99. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 100. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 101. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
  • TABLE 102. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
  • TABLE 103. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
  • TABLE 104. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
  • TABLE 105. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
  • TABLE 106. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
  • TABLE 107. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
  • TABLE 108. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
  • TABLE 109. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 110. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 111. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 112. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 113. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
  • TABLE 114. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
  • TABLE 115. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 116. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 117. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
  • TABLE 118. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
  • TABLE 119. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
  • TABLE 120. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
  • TABLE 121. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
  • TABLE 122. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
  • TABLE 123. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
  • TABLE 124. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
  • TABLE 125. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 126. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 127. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
  • TABLE 130. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
  • TABLE 131. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 132. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 133. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
  • TABLE 134. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
  • TABLE 135. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
  • TABLE 136. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
  • TABLE 137. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
  • TABLE 138. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
  • TABLE 139. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
  • TABLE 140. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
  • TABLE 141. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 142. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 143. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 144. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 145. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
  • TABLE 146. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
  • TABLE 147. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 148. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 149. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
  • TABLE 150. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
  • TABLE 151. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
  • TABLE 152. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
  • TABLE 153. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
  • TABLE 154. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
  • TABLE 155. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
  • TABLE 156. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
  • TABLE 157. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 158. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 159. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 160. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 161. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
  • TABLE 162. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
  • TABLE 163. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 164. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 165. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
  • TABLE 166. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
  • TABLE 167. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
  • TABLE 168. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
  • TABLE 169. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
  • TABLE 170. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
  • TABLE 171. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
  • TABLE 172. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
  • TABLE 173. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 174. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 175. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 176. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 195. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 196. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 197. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
  • TABLE 198. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
  • TABLE 199. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 200. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 201. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
  • TABLE 204. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
  • TABLE 205. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
  • TABLE 206. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
  • TABLE 207. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
  • TABLE 208. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
  • TABLE 209. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 210. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 211. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 212. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 213. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
  • TABLE 214. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
  • TABLE 215. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 216. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 217. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
  • TABLE 218. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
  • TABLE 219. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
  • TABLE 220. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
  • TABLE 221. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
  • TABLE 222. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
  • TABLE 223. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
  • TABLE 224. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
  • TABLE 225. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 226. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 227. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 228. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 229. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
  • TABLE 230. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
  • TABLE 231. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 232. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 233. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
  • TABLE 234. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
  • TABLE 235. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
  • TABLE 236. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
  • TABLE 237. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
  • TABLE 238. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
  • TABLE 239. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
  • TABLE 240. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
  • TABLE 241. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 242. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 243. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 244. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 245. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
  • TABLE 246. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
  • TABLE 247. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 248. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 249. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
  • TABLE 250. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
  • TABLE 251. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
  • TABLE 252. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
  • TABLE 253. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
  • TABLE 254. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
  • TABLE 255. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
  • TABLE 256. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
  • TABLE 257. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 258. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 259. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 260. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 261. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
  • TABLE 262. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
  • TABLE 263. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 264. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 265. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
  • TABLE 266. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
  • TABLE 267. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
  • TABLE 268. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
  • TABLE 269. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
  • TABLE 270. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
  • TABLE 271. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
  • TABLE 272. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
  • TABLE 273. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 274. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 275. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 276. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 277. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
  • TABLE 278. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
  • TABLE 279. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 280. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 281. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
  • TABLE 282. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
  • TABLE 283. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
  • TABLE 284. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
  • TABLE 285. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
  • TABLE 286. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
  • TABLE 287. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
  • TABLE 288. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
  • TABLE 289. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 290. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 291. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 292. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 293. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
  • TABLE 294. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
  • TABLE 295. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 296. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 297. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
  • TABLE 298. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
  • TABLE 299. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
  • TABLE 300. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
  • TABLE 301. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
  • TABLE 302. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
  • TABLE 303. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
  • TABLE 304. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
  • TABLE 305. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 306. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 307. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 308. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 309. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
  • TABLE 310. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
  • TABLE 311. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 312. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 313. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
  • TABLE 314. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
  • TABLE 315. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
  • TABLE 316. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
  • TABLE 317. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
  • TABLE 318. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
  • TABLE 319. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
  • TABLE 320. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
  • TABLE 321. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 322. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 323. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 324. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 325. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
  • TABLE 326. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
  • TABLE 327. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 328. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 329. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
  • TABLE 330. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
  • TABLE 331. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
  • TABLE 332. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
  • TABLE 333. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
  • TABLE 334. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
  • TABLE 335. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
  • TABLE 336. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
  • TABLE 337. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 338. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 339. TAIWAN ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 340. TAIWAN ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 341. TAIWAN ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
  • TABLE 342. TAIWAN ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
  • TABLE 343. TAIWAN ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 344. TAIWAN ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 345. TAIWAN ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
  • TABLE 346. TAIWAN ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
  • TABLE 347. TAIWAN ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
  • TABLE 348. TAIWAN ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)

T